The Progeria Research Foundation ("PRF"), a nonprofit research organization dedicated to developing treatments and the cure for Hutchinson-Gilford Progeria Syndrome ("Progeria"), and Forge Biologics, ...

A University of Maryland-led discovery could spur the development of new and improved treatments for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder with no known cure that causes ...

Forge Biologics will provide process development and manufacturing services to support gene therapy for ultrarare disease Progeria ...

The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...

Sentynl, a Zydus Group company, receives worldwide proprietary rights to Zokinvy, adding to portfolio of biopharmaceuticals for rare and ultra-rare diseases Zokinvy is approved in the U.S. (2020), ...

A rare, but fatal genetic disease that accelerates aging in children, progeria, could soon have a cure, The New York Times reported July 24. The disease affects only 1 in every 4 million to 8 million ...

Progeria is an extremely rare genetic disease of childhood characterised by dramatic, premature ageing. The condition, which derives its name from “geras”, the Greek word for old age, is estimated to ...

A new research paper was published in Volume 17, Issue 9 of Aging-US on August 27, 2025, titled, "Deregulated miR-145 and miR-27b in Hutchinson-Gilford progeria syndrome: implications for adipogenesis ...

Proposed working model. Progerin accumulation induces stress, leading to attenuation of Ang2 expression and secretion and its downstream effector. Ang2-induced activation of Tie2 receptor activates ...

(Gray News) – The longest-living survivor of progeria has died at the age of 28. In a Facebook post, the Progeria Research Foundation announced that Sammy Basso passed away Saturday. “Sammy was the ...